These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30538643)

  • 1. Preventing Peritoneal Dialysis-Associated Fibrosis by Therapeutic Blunting of Peritoneal Toll-Like Receptor Activity.
    Raby AC; Labéta MO
    Front Physiol; 2018; 9():1692. PubMed ID: 30538643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
    Raby AC; González-Mateo GT; Williams A; Topley N; Fraser D; López-Cabrera M; Labéta MO
    Kidney Int; 2018 Aug; 94(2):346-362. PubMed ID: 29861057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.
    Raby AC; Colmont CS; Kift-Morgan A; Köhl J; Eberl M; Fraser D; Topley N; Labéta MO
    J Am Soc Nephrol; 2017 Feb; 28(2):461-478. PubMed ID: 27432741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Toll-like receptor 4 in high-glucose-induced inflammatory and fibrosis markers in human peritoneal mesothelial cells.
    Choi SY; Ryu HM; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Int Urol Nephrol; 2017 Jan; 49(1):171-181. PubMed ID: 27722989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and treatment of peritoneal membrane failure.
    Saxena R
    Pediatr Nephrol; 2008 May; 23(5):695-703. PubMed ID: 17891546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
    Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
    Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.
    de Lima SM; Otoni A; Sabino Ade P; Dusse LM; Gomes KB; Pinto SW; Marinho MA; Rios DR
    Clin Chim Acta; 2013 Jun; 421():46-50. PubMed ID: 23466603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.
    Yang CY; Chau YP; Chen A; Lee OK; Tarng DC; Yang AH
    World J Nephrol; 2017 May; 6(3):111-118. PubMed ID: 28540200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
    Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
    Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for preventing peritoneal fibrosis in peritoneal dialysis patients: new insights based on peritoneal inflammation and angiogenesis.
    Zhang Z; Jiang N; Ni Z
    Front Med; 2017 Sep; 11(3):349-358. PubMed ID: 28791669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Mouse Model of Peritoneal Dialysis: Combination of Uraemia and Long-Term Exposure to PD Fluid.
    Ferrantelli E; Liappas G; Keuning ED; Vila Cuenca M; González-Mateo G; Verkaik M; López-Cabrera M; Beelen RH
    Biomed Res Int; 2015; 2015():106902. PubMed ID: 26587530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors TLR4 (Asp299Gly and Thr399Ile) and TLR2 (Arg677Trp and Arg753Gln) gene polymorphisms in end-stage renal disease patients on peritoneal dialysis.
    Singh K; Prasad KN; Mishra P; Khatoon J; Prasad N; Gupta A; Srivastava JK
    Int Urol Nephrol; 2015 Dec; 47(12):2031-7. PubMed ID: 26490558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Tyrosine Kinase Receptors in Peritoneal Fibrosis.
    Wang L; Zhuang S
    Perit Dial Int; 2015; 35(5):497-505. PubMed ID: 26450477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment.
    Poon PY; Lan HY; Kwan BC; Huang XR; Chow KM; Szeto CC; Li PK
    Nephrology (Carlton); 2017 Feb; 22(2):125-132. PubMed ID: 26857687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of research progress on mechanisms of peritoneal fibrosis related to peritoneal dialysis.
    Li J; Liu Y; Liu J
    Front Physiol; 2023; 14():1220450. PubMed ID: 37817984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis: a viable renal replacement therapy option.
    Saxena R
    Am J Med Sci; 2005 Jul; 330(1):36-47. PubMed ID: 16020998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserving the peritoneal membrane in long-term peritoneal dialysis patients.
    Ditsawanon P; Aramwit P
    J Clin Pharm Ther; 2015 Oct; 40(5):508-516. PubMed ID: 26280248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-based peritoneal dialysis fluids downregulate toll-like receptors and trigger hyporesponsiveness to pathogen-associated molecular patterns in human peritoneal mesothelial cells.
    Wu J; Yang X; Zhang YF; Wang YN; Liu M; Dong XQ; Fan JJ; Yu XQ
    Clin Vaccine Immunol; 2010 May; 17(5):757-63. PubMed ID: 20200188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
    López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
    Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on mechanisms of ultrafiltration failure.
    Kim YL
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.